Sun Pharma And Ranbaxy

Rediff.com » News » Sun Pharma And Ranbaxy

News for Sun Pharma And Ranbaxy

Business

Blackstone, Baring in race to acquire up to 20% stake in Cipla

In one of the largest potential transactions this year, private-equity majors Blackstone and Baring have initiated talks with the Hamied family, the promoters of pharmaceutical firm Cipla, to......

Will Sudhir Valia, Suraksha's 'deal maker' manage to bag Jaypee Infra?

Suraksha started by funding developers for projects, and then evolved into realty angel investing. Dev Chatterjee reports. IMAGE: Suraksha Smart City - Vasai-Virar's biggest township under......

Why Sun Pharma stock will remain under pressure

The weakness in the stock was because of inspections by the American drug regulator at its Halol plant in Gujarat which resulted in eight observations, as well as a downward revision of speciality......

The mighty fall of India's business czars

Who is to take their place?Will a new generation of entrepreneurs start up with better business sense, or at least better luck?But the so-called unicorns are mostly copy-cat entrepreneurs whose......

Lessons from the Fortis/Raymond family feuds

'Nothing in this world is permanent. So also in business.''And more so in family businesses where family issues often influence business decisions,' point out S Subramanian and Nupur Pavan Bang.......

Rediff News

Sun Pharma And Ranbaxy

News for Sun Pharma And Ranbaxy

Blackstone, Baring in race to acquire up to 20% stake in Cipla

Will Sudhir Valia, Suraksha's 'deal maker' manage to bag Jaypee Infra?

Why Sun Pharma stock will remain under pressure

The mighty fall of India's business czars

Lessons from the Fortis/Raymond family feuds

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS